Brevan Howard Capital Management LP Viking Therapeutics, Inc. Transaction History
Brevan Howard Capital Management LP
- $12.7 Billion
- Q1 2024
A detailed history of Brevan Howard Capital Management LP transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 6,476 shares of VKTX stock, worth $326,843. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,476Holding current value
$326,843% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding VKTX
# of Institutions
426Shares Held
63.1MCall Options Held
7.39MPut Options Held
5.13M-
Black Rock Inc. New York, NY8.27MShares$418 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.79MShares$393 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY3.59MShares$181 Million3.55% of portfolio
-
State Street Corp Boston, MA3.33MShares$168 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA2.33MShares$117 Million0.02% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $3.87B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...